1. The cause and prevention of postoperative, intraperitoneal adhesions;Ellis;Surg. Gynecol. Obstet.,1971
2. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer;Dedrick;Cancer Treat. Rep.,1978
3. Intraperitoneal distribution of 32P chromic phosphate suspension in the dog;Tewfik;Int. J. Radiat. Oncol. Biol. Phys.,1979
4. The ability of recombinant tissue plasminogen activator to inhibit post radical pelvic surgery adhesion in the dog model;Montz;Am. J. Obstet. Gynecol.,1991
5. Closure of pericardium using expanded polytetrafluoroethylene surgical membrane (Gore-SM): Clinical experience;Minale;Thorac. Cardiovasc.,1987